全文获取类型
收费全文 | 5163篇 |
免费 | 561篇 |
国内免费 | 4篇 |
出版年
2021年 | 81篇 |
2019年 | 47篇 |
2018年 | 74篇 |
2017年 | 55篇 |
2016年 | 100篇 |
2015年 | 127篇 |
2014年 | 169篇 |
2013年 | 211篇 |
2012年 | 261篇 |
2011年 | 280篇 |
2010年 | 200篇 |
2009年 | 144篇 |
2008年 | 288篇 |
2007年 | 256篇 |
2006年 | 194篇 |
2005年 | 196篇 |
2004年 | 196篇 |
2003年 | 173篇 |
2002年 | 188篇 |
2001年 | 104篇 |
2000年 | 97篇 |
1999年 | 98篇 |
1998年 | 72篇 |
1997年 | 59篇 |
1996年 | 66篇 |
1995年 | 53篇 |
1994年 | 48篇 |
1993年 | 49篇 |
1992年 | 93篇 |
1991年 | 102篇 |
1990年 | 83篇 |
1989年 | 81篇 |
1988年 | 92篇 |
1987年 | 59篇 |
1986年 | 66篇 |
1985年 | 62篇 |
1984年 | 70篇 |
1983年 | 56篇 |
1981年 | 44篇 |
1980年 | 55篇 |
1979年 | 51篇 |
1978年 | 57篇 |
1977年 | 38篇 |
1976年 | 52篇 |
1975年 | 39篇 |
1974年 | 37篇 |
1973年 | 52篇 |
1972年 | 42篇 |
1970年 | 40篇 |
1969年 | 43篇 |
排序方式: 共有5728条查询结果,搜索用时 46 毫秒
991.
Samantaray S Smith JA Das A Matzelle DD Varma AK Ray SK Banik NL 《Neurochemical research》2011,36(10):1809-1816
Spinal cord injury (SCI), depending on the severity of injury, leads to neurological dysfunction and paralysis. Methylprednisolone,
the only currently available therapy renders limited protection in SCI. Therefore, other therapeutic agents must be tested
to maximize neuroprotection and functional recovery. Previous data from our laboratory indicate that estrogen (17β-estradiol)
at a high dose may attenuate multiple damaging pathways involved in SCI and improve locomotor outcome. Since use of high dose
estrogen may have detrimental side effects and therefore may never be used in the clinic, the current study investigated the
efficacy of this steroid hormone at very low doses in SCI. In particular, we tested the impact of dosing (1–10 μg/kg), mode
of delivery (intravenous vs. osmotic pump), and delay in estrogen application (15 min–4 h post-SCI) on microgliosis and neuronal
death in acute SCI in rats. Treatment with 17β-estradiol (1–10 μg/kg) significantly reduced microglial activation and also
attenuated apoptosis of neurons compared to untreated SCI animals. The attenuation of cell death and inflammation by estrogen
was observed regardless of mode and time of delivery following injury. These findings suggest estrogen as a potential agent
for the treatment of individuals with SCI. 相似文献
992.
Ray JG Ghosh R Mallick D Swain N Gandhi P Ram SS Selvaraj S Rathore A Mathummal S Chakraborty A 《Biological trace element research》2011,144(1-3):295-305
In order to ascertain possible correlation between alterations in trace elemental profile and the progression or regression of two most common potentially malignant disorders affecting oral cavity, namely oral submucous fibrosis and leukoplakia, blood from 60 patients from each group of patients as well from 30 healthy individuals was analyzed for elemental profiling employing EDXRF technique. Out of the 16 detected elements (K, Si, Ca, V, Cr, Ni, Mn, Fe, Cu, Zn, Se, Br, Rb, Sr, Co, and Pb), Mn, Fe, Zn, Br, and Co showed remarkable alteration in their profile in both leukoplakia and oral submucous fibrosis patients with respect to the normal healthy individuals. While Zn, Br, and Fe reflected similar changes--showing gross depletion in both the diseased groups, Mn and Co depicted inverse pattern of alterations in their concentrations in the two types of precancerous disorders when compared to the control subjects. 相似文献
993.
994.
995.
Kar A Fushimi K Zhou X Ray P Shi C Chen X Liu Z Chen S Wu JY 《Molecular and cellular biology》2011,31(9):1812-1821
Regulation of tau exon 10 splicing plays an important role in tauopathy. One of the cis elements regulating tau alternative splicing is a stem-loop structure at the 5' splice site of tau exon 10. The RNA helicase(s) modulating this stem-loop structure was unknown. We searched for splicing regulators interacting with this stem-loop region using an RNA affinity pulldown-coupled mass spectrometry approach and identified DDX5/RNA helicase p68 as an activator of tau exon 10 splicing. The activity of p68 in stimulating tau exon 10 inclusion is dependent on RBM4, an intronic splicing activator. RNase H cleavage and U1 protection assays suggest that p68 promotes conformational change of the stem-loop structure, thereby increasing the access of U1snRNP to the 5' splice site of tau exon 10. This study reports the first RNA helicase interacting with a stem-loop structure at the splice site and regulating alternative splicing in a helicase-dependent manner. Our work uncovers a previously unknown function of p68 in regulating tau exon 10 splicing. Furthermore, our experiments reveal functional interaction between two splicing activators for tau exon 10, p68 binding at the stem-loop region and RBM4 interacting with the intronic splicing enhancer region. 相似文献
996.
Though HIV/AIDS poses serious risks to economic security, there is very little economics literature quantifying awareness and knowledge of this disease and their principal socioeconomic determinants. This is what the present study attempts to do in the context of India, which faces a significant threat from HIV/AIDS. The study is based on India's National Family Health Surveys covering the period of economic reforms and beyond. The contribution is both methodological and empirical. The study shows that the recent multi-dimensional deprivation approach to poverty can also be used to measure and analyse awareness and lack of knowledge of HIV/AIDS. The use of decomposable multi-dimensional measures helps in identifying regions, socioeconomic groups and aspects of HIV knowledge that should be targeted in policy interventions. The study identifies the importance of safe sex practices as an area that needs to be targeted in future information campaigns. The study also explores the impact of increased female autonomy in health and economic decision-making on their and their partners' knowledge of the disease, along with a host of other economic and demographic determinants. 相似文献
997.
998.
999.
The endocannabinoid system has emerged as an important regulator of immune responses, with the cannabinoid receptor 2 (CB2) and its principle ligand 2-archidonoylglycerol playing a major role. How CB2 regulates B cell functions is not clear, even though they express the highest levels of CB2 among immune cell subsets. In this study, we show that CB2-deficient mice have a significant reduction in the absolute number of marginal zone (MZ) B cells and their immediate precursor, transitional-2 MZ precursor. The loss of MZ lineage cells in CB2(-/-) mice was shown to be B cell intrinsic using bone marrow chimeras and was not due to a developmental or functional defect as determined by B cell phenotype, proliferation, and Ig production. Furthermore, CB2(-/-) B cells were similar to wild type in their apoptosis, cell turnover, and BCR and Notch-2 signaling. We then demonstrated that CB2(-/-) MZ lineage B cells were less efficient at homing to the MZ and that their subsequent retention was also regulated by CB2. CB2(-/-) mice immunized with T-independent Ags produced significantly less Ag-specific IgM. This study demonstrates that CB2 positively regulates T-independent immune responses by controlling the localization and positioning of MZ lineage cells to the MZ. 相似文献
1000.
Ni YG Di Marco S Condra JH Peterson LB Wang W Wang F Pandit S Hammond HA Rosa R Cummings RT Wood DD Liu X Bottomley MJ Shen X Cubbon RM Wang SP Johns DG Volpari C Hamuro L Chin J Huang L Zhao JZ Vitelli S Haytko P Wisniewski D Mitnaul LJ Sparrow CP Hubbard B Carfí A Sitlani A 《Journal of lipid research》2011,52(1):78-86
Proprotein convertase subtilisin-like/kexin type 9 (PCSK9) regulates LDL cholesterol levels by inhibiting LDL receptor (LDLr)-mediated cellular LDL uptake. We have identified a fragment antigen-binding (Fab) 1D05 which binds PCSK9 with nanomolar affinity. The fully human antibody 1D05-IgG2 completely blocks the inhibitory effects of wild-type PCSK9 and two gain-of-function human PCSK9 mutants, S127R and D374Y. The crystal structure of 1D05-Fab bound to PCSK9 reveals that 1D05-Fab binds to an epitope on the PCSK9 catalytic domain which includes the entire LDLr EGF(A) binding site. Notably, the 1D05-Fab CDR-H3 and CDR-H2 loops structurally mimic the EGF(A) domain of LDLr. In a transgenic mouse model (CETP/LDLr-hemi), in which plasma lipid and PCSK9 profiles are comparable to those of humans, 1D05-IgG2 reduces plasma LDL cholesterol to 40% and raises hepatic LDLr protein levels approximately fivefold. Similarly, in healthy rhesus monkeys, 1D05-IgG2 effectively reduced LDL cholesterol 20%-50% for over 2 weeks, despite its relatively short terminal half-life (t(1/2) = 3.2 days). Importantly, the decrease in circulating LDL cholesterol corresponds closely to the reduction in free PCSK9 levels. Together these results clearly demonstrate that the LDL-lowering effect of the neutralizing anti-PCSK9 1D05-IgG2 antibody is mediated by reducing the amount of PCSK9 that can bind to the LDLr. 相似文献